The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease
Open Access
- 1 January 2024
- journal article
- review article
- Published by Discovery Medicine in Discovery Medicine
- Vol. 36 (185) , 1127-1138
Abstract
As the most common type of primary liver cancer, hepatocellular carcinoma (HCC) is reportedly the third leading cause of cancer-related death globally. Advanced steatotic liver disease (SLD) emerges as the most prominent contributor to HCC worldwide. In this paper, we review the extrahepatic features of metabolic dysfunction-associated SLD that exacerbate the risk for HCC, including insulin resistance, obesity-related factors such as physical inactivity and dietary patterns, as well as influences of genetics, ethnicity, gender-specific hormonal differences, alcohol-associated liver disease (ALD), smoking habits, and alterations in gut microbiota. Additionally, the mechanisms underlying how these extrahepatic features contribute to the development, as well as the detection and surveillance of HCC, are elaborated. With a better understanding of these factors, targeted interventions can be designed to prevent HCC development or ameliorate its clinical outcomes.Keywords
This publication has 106 references indexed in Scilit:
- Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLDHepatology Communications, 2021
- Abbreviated Magnetic Resonance Imaging for HCC SurveillanceClinical Liver Disease, 2021
- Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver DiseaseHepatology, 2019
- Diagnosis and Pharmacotherapy of Alcohol Use DisorderJAMA, 2018
- Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver DiseaseHepatology, 2018
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐upHepatology, 2014
- Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitisHepatology, 2013
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare databaseHepatology, 2011
- Acamprosate for alcohol dependenceCochrane Database of Systematic Reviews, 2010
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinomaCancer, 2010